Summary
Work History
Education
Skills
CLINICAL RESEARCH STUDIES
Timeline
GeneralManager

CAROL SICHELMEIER

Petaluma,CA

Summary

A highly skilled and versatile Senior Director, possessing substantial experience in clinical research, is seeking employment with a company that is on an upward trajectory. Hands-on leadership and management background, with a proven track record of success in streamlining processes and restructuring operations.

Over 20 years of experience managing large-scale projects in clinical research, and an established history of effectively motivating, coaching, and building teams to achieve company objectives.

Possesses a strategic leadership style and utilize a transparent decision-making approach to optimize operations and support teams effectively.

A dynamic research career with a significant focus on clinical quality assurance, clinical trial establishment, clinical trial and program management, and other clinical research areas. Adept at building strong relationships with vendors, key stakeholders, and executive teams. Committed to meeting project deliverables and timelines while identifying critical paths to timelines and mitigating risks. Ensuring compliance with all codes of federal regulations and ICH guidelines for good clinical practices. Expertise in clinical research is an asset to any organization.

Work History

Clinical Site Manager/Monitor

Allurion Technologies
Natick, MA
03.2023 - Current
  • Ensure that all research being conducted complies with the standards and policies of the organization.
  • Identify new potential Investigators through ongoing collaborations with internal and external stakeholders.
  • Plan, schedule, and conduct various GxP audits throughout all stages of clinical research, which includes project-related, system, supplier, and safety audits.
  • Collect and review responses to audit observations and ensure that inadequate or delayed responses are escalated appropriately to meet timelines and obtain satisfactory quality responses.
  • Develop Site relationships (incl. Contract Research, Organization issue management, and non-registration/investigator-sponsored research Studies).
  • Conducts pre-study visits as appropriate.
  • Conduct initiation visits to ensure Investigator and site personnel receive adequate protocol-specific training before site activation.
  • Review site activities and quality through on-site and off-site visits.
  • Conducts monitoring activities and ensures the safety and protection of study subjects as per the monitoring plan, procedural documents, protocol, ICH/GCP Guidelines, and other local regulations as applicable.
  • Collaborate with Risk Management and the Director of Quality to conduct, review, analyze, and summarize findings of audit plans for internal business units and delegated partners.
  • Identify opportunities for improvement, prioritize problems, and create performance improvement plans.
  • Contribute creative solutions, take ownership of daily assignments, and ensure seamless communication and systematic completion of routine and special projects.
  • Work with appropriate teams and departments to manage and plan implementation of patient safety/quality of care initiatives across the organization.
  • Ability to use data to assess risks, identify issues, and make appropriate decisions.
  • Serve as a point of contact for Sites.
  • Provide training to sites.
  • Ensure completeness and quality of data submitted from study sites.
  • Ensures eCRF data is available and current by using the available systems to follow site activities.
  • Oversees activities of site personnel over whom there is no direct authority.
  • Motivate/influence sites to meet study objectives, including enrolment and retention goals.
  • Demonstrate flexibility and adaptability when communicating with different stakeholders utilizing the most appropriate communication method.
  • Anticipate, identify and proactively supports the site in resolving issues as they occur.
  • Appropriately document and promptly escalates severe or outstanding persistent problems to the Sr. VP, Clinical Development.
  • Initiate, recommend, document, and communicate corrective actions as needed and follows up to ensure corrective/preventive actions based on root cause analysis are implemented.
  • Involvement in Regulatory Compliance audit/inspection process, as needed. This includes the development and implementation of site corrective and preventive actions.
  • Prepare and submit written reports, both monitoring and administrative, in a timely, accurate, concise, professional, and objective manner.
  • Support ensuring access to eDC and vendor systems for clinical trial site personnel.
  • Support equipment calibration and tracking.
  • Support coordination and ensure local database lock timelines are met as required.
  • Proactively identify and resolve potential problems at both site and country level.
  • Engage with the Clinical VP, Clinical Development to assist in resolving more complex issues.
  • Contribute significantly to the study team and coach site staff to enhance site and hub performance.
  • Serve as a critical resource for colleagues by providing 21 CFR/ISO guidance, leading training, and mentoring to other team members through a mentoring process using informal and formal presentations.

Sr. Director, Clinical Operations (Early Dev).

Circle Pharma
South San Francisco
03.2023 - 01.2024
  • Collaborate with the team leader to ensure alignment of expectations, deliverables, and timelines across the team.
  • Provide strategic input and operational expertise in developing Clinical Development Plans (CDP) for one or more clinical programs.
  • Manage the timelines and support the clinical strategy for the programs, including developing study strategy operational plans, enrolment models, and risk management strategies.
  • Evaluate multiple development scenarios, including risks, mitigation, timelines, and budgets for the strategic execution of the Clinical Development Plan.
  • Develop high-quality study synopsis/protocol in partnership with key stakeholders, ensuring all relevant partners contribute to the process.
  • Oversee the operational execution and delivery of the assigned clinical programs in compliance with quality standards, including ICH GCP local regulations, and on-budget.
  • Create and maintain integrated project timelines and prepare internal documents in partnership with the team leader and key stakeholders.
  • Lead the development of team practices and operating principles with a focus on cross-functional input and accountability.
  • Act as an integrator within the Project Team, across the enterprise, and with external partners to ensure alignment and connect best practices.
  • Develop and coordinate resource planning to ensure adequate resources are applied to the project.
  • Coach project team members and others to drive excellence and accountability, promote knowledge-sharing, and embody a culture of improvement and progress.
  • Partner with collaborators and external stakeholders to form a solid strategic alliance and advance company goals.
  • Provide leadership to assigned Clinical Program(s) and ensure studies within the program are managed per the company’s overall program goals, timeline, budget, and quality expectations.
  • Assist in planning and executing clinical development initiatives such as scenario planning, timeline forecasting, program-level feasibility assessments, resource and budget estimation, and operational strategy development.
  • Oversee clinical trials within a Clinical Program to ensure compliance with applicable regulations and company procedures.
  • Develop and implement clinical monitoring standards and best practices for effective clinical monitoring of investigational sites.
  • Provide leadership in developing the clinical trial management, budget, and resourcing strategy at a program level and collaborate with senior management to ensure alignment of resources and timelines across clinical programs.
  • Provide updates on trial status, metrics, budget, and risks to relevant stakeholders.
  • Guide and support trial management activities related to the drug development process, including budget management, study management, CRO/vendor oversight, risk mitigation, and Good Clinical Practice (GCP).
  • Collaborate in developing Clinical Operations Standard Operating Procedures (SOP) and Work Instructions (WI) to ensure compliance with FDA regulations.
  • Develop clinical monitoring SOPs, tools, and document templates (e.g., monitoring plan and visit report templates), and oversee the development, implementation, and oversight of novel monitoring approaches.

Associate Director

Zogenix
Emeryville, CA
07.2020 - Current
  • Provide program leadership and operational strategy for Zogenix's ZX008 product pipeline
  • Identify, design, and implement process and system improvements
  • Identify training needs and participate in training interventions calls to meet quality standards
  • Participate in on-hands and strategic QA oversight to ensure compliance with GxP, regulatory requirements, clinical study protocols, and SOPs
  • Author, review, and approve GxP SOPs, work instructions, and other controlled documents in collaboration with key clinical development functions and stakeholders
  • Successfully led strategic planning and operational execution of clinical trials for 1 - 2 programs, in collaboration with cross-functional study teams and clinical development leadership
  • Performs task related to vendor qualifications and support internal compliance initiatives
  • Support vendor management and qualifications activities for GxP service providers
  • Successfully led and managed the execution of Phase III Global studies in collaboration with the lead Medical Monitor and Study Management Team to ensure that the study meets milestone deliverables are met per the approved clinical plan and corporate goals
  • Accountable and responsible for clinical operations planning and implementation of clinical development program including scenario planning, forecasting of timelines, assessment program level feasibility, estimation of resources and budget, and development of operational strategies
  • Successfully lead program-level clinical operations team and collaborates with cross-functional team members
  • Developed RFPs, lead discussions on bid defense, vendor identifications/selection and contracting of vendors (i.e
  • ECHO/ECG, eDiary, EDC, RTSM, etc.)
  • Developed Standard Operating Procedures, working instructions, and training plans
  • Contribute and facilitate Clinical Operations' GCP compliance activities, reporting, and inspection readiness systems and activities
  • Prepare study updates and key metrics for clinical leadership and executive management
  • Represented Clinical Operations at internal cross-functional team meetings, contribute to strategic planning and provide critical updates as needed
  • Partnered with cross-functional team members in key departments such as Regulatory, Clinical Development, Non-Clinical Development, Translational Sciences, CMC, Legal, and Finance.

Global Studies Manager (contract)

Roche/Genentech
South San Francisco, CA
09.2018 - 05.2020
  • Developed operational plans including site monitoring strategies, risk mitigation strategies, and trial budgets
  • Managed multiple study vendors, including CROs, Central Laboratory, Central Imaging, and Interactive Response Technology
  • Coached, mentored, supported, and provided study-specific direction to Study Management Team Members
  • Established study milestones and ensured tracking and reporting of study metrics
  • Served as back-up lead to the study management team and global team meetings
  • Executed the local implementation of the audit quality and risk management plans which identify critical issues for the country level operations team
  • Performed data listing review against source documents for soft and hard data locks
  • Represented Genentech/Roche through excellent customer service and attention to customers when face-to-face or through phone conversations
  • Developed and maintained effective working relationships cross-functionally, and acted as the primary contact for key stakeholders (e.g
  • GSL, OPL, and Service Providers)
  • Developed complex excel tracking spreadsheet in order to track study images (e.g
  • Received, graded, missed, etc.) in order to ensure primary analysis and study endpoint is met.

Associate Director, Clinical Operations

Exelixis, Inc.
South San Francisco, CA
01.2017 - 07.2018
  • Successfully led and managed the execution of Phase I-III Global studies in collaboration with the lead Medical Monitor and Study Management Team to ensure that the study meets milestone deliverables per the approved clinical plan and corporate goals
  • Identify, design, and implement process and system improvements
  • Identify training needs and participate in training interventions calls to meet quality standards
  • Participate in on-hands and strategic QA oversight to ensure compliance with GxP, regulatory requirements, clinical study protocols, and SOPs
  • Author, review, and approve GxP SOPs, work instructions, and other controlled documents in collaboration with key clinical development functions and stakeholders
  • Performed clinical site qualification, contract negotiation, IRB/ethical committee submissions, protocol initiation, site monitoring, quality oversight visits, for-cause visits, and site close-out (International/US based)
  • Performs task related to vendor qualifications and support internal compliance initiatives
  • Support vendor management and qualifications activities for GxP service providers
  • Handled the reporting of vendors' quarterly invoice and accruals with the finance group
  • Led study team meetings (e.g
  • Study Management Team, Global Team Meetings, etc.) and provide periodic study updates including risk and mitigation strategies to the product's Oncology Product Team and Senior Leadership
  • Collaborated with the Data Management and Biometrics group on the management of the data and reporting of study data per the approved clinical plan
  • Managed, developed, and supported the Clinical Operations team members assigned to the studies
  • Created Standard Operating Procedures, working instructions, and training plans
  • Directed, collaborated and influenced the activities of functional team members through the Study Team Management
  • Managed operational transitions initiated by changes in regulatory requirements
  • Managed five concurrent Phase I-III start-up studies with minimal resources and oversight
  • Oversaw study vendors per the study's outsourcing plan and budget, including CROs, Central Laboratory, Central Imaging, and Interactive Response Technology
  • Ensured operational readiness by troubleshooting and resolving process and analytical issues during study conduct
  • Conducted feasibility studies and contributed to the company's project planning process
  • Provided information on the study protocol, final study report, and template informed consent forms
  • Maintained communication and information exchange with technical counterparts at CRO/CMO and other global sites
  • Enhanced process improvements by engaging analytical subject matter experts
  • Coordinated multiple investigator meetings with our preferred vendors.

Sr. Clinical Operations Manager/Global Study Lead

BioMarin Pharmaceutical, Inc.
Novato, CA
03.2014 - 01.2017
  • Oversaw program development of 4 phase 1 trials from startup-to finalization) Managed, coached, and developed junior staff in order to maximize their capabilities and contributions to provide high-quality deliverables
  • Collaborated with key stakeholders to ensure continuous harmonized operations of global activities to maintain high standards for functioning in a matrix environment
  • Managed study operational plans and CRO activities, including project timelines and quality of deliverables, and approved trial budget(s) throughout the life of the assigned clinical program(s)/studies
  • Successfully conducted clinical site qualification, contract negotiation, IRB/ethical committee submissions, protocol initiation, site monitoring, quality oversight visits, for-cause visits, and site close-out (International/US base)
  • Evaluated clinical data and coordinated data query resolutions during times of primary analysis, timeline push, and program closure
  • Identified, resolved, mitigated and escalated risks and/or issues to the study team
  • Maintained frequent and meaningful contact with CROs to assess performance and provide guidance as needed
  • Managed cross-functional study teams and vendor operational meetings to ensure compliance with operational responsibilities
  • Provided leadership for clinical operations related issues and advise the management team on potential issues and solutions
  • Developed and managed study/program timelines (including recruitment).

Sr. Clinical Research Associate

BioMarin Pharmaceutical, Inc.
Novato, CA
02.2010 - 03.2014
  • Activated and managed over 30 sites as a Sr
  • CRA
  • Provided clinical trial management services to sites with a focus on ensuring Good Clinical Practice and International Conference on Harmonization (GCP/ICH), patient safety, patient enrollment/recruitment
  • Developed, trained, and mentored Clinical Research Associates and Clinical Program Managers on study protocols and company processes
  • Successfully conducted clinical site qualification, contract negotiation, IRB/ethical committee submissions, protocol initiation, site monitoring, quality oversight visits, for-cause visits, and site close-out (International/US base)
  • Managed and approved trial budgets throughout the life of the assigned clinical trials
  • Reviewed clinical data and coordinated data query resolutions during times of primary analysis, timeline push, and program closure
  • Built and maintained positive working relationships with Clinical Investigators and clinical site personnel
  • Successfully conducted clinical site qualification, contract negotiation, IRB/ethical committee submissions, protocol initiation, site monitoring, quality oversight visits, for-cause visits, and site close-out (International/US base).

Sr. Clinical Research Associate (contract)

Abbott Vascular
Santa Clara, CA
06.2008 - 09.2009
  • Directly managed and supported over 84 sites on three Post-Market Carotid Studies
  • Designed, implemented, and monitored clinical studies of new and modified in-vitro diagnostic products
  • Monitored clinical studies, ensuring site compliance with the clinical protocol and ICH/GCP guidelines to assure subjects rights, safety, and welfare are protected, and to ensure data integrity through completeness
  • Participated in the preparation of regulatory submissions and international registration packages
  • Proposed and negotiated budgets for clinical studies
  • Obtained and reviewed all required essential documents necessary for study initiation
  • Collaborated with Statistical Support with the collection and statistical analysis of clinical data.

Clinical Program Manager (contract)

CoMentis, Inc.
South San Francisco, CA
06.2007 - 06.2008
  • Managed resources, timelines, and budgets Phase I/II studies to meet department goals
  • Oversaw daily activities involved in clinical trials, including managing the direction, planning, and implementation of clinical research trials
  • Identified program level resource gaps and proposed solutions
  • Assisted in evaluating clinical data and coordinates data query resolutions during times of primary analysis, timeline push, and program closure
  • Performed Interim Monitoring visits to observe and assess that protocol guidelines are met/conducted (USA based)
  • Developed and submitted request for proposals (RFPs) to full-service CROs
  • Created and submitted IND Annual Reports
  • Designed and created the Clinical Study Report (CSR) with the Medical Writer and Medical Director
  • Worked closely with team members to deliver project requirements, develop solutions and meet deadlines.

Clinical Trial Manager

Genentech, Inc.
South San Francisco, CA
08.2005 - 07.2007
  • Managed multiple phase I, II, III, and Phase IV studies across multiple disease indications (e.g
  • Immunology, Oncology, Pulmonary, AMD-wet/dry)
  • Maintained full accountability for all assigned studies at Regional/Country Level, including adherence to quality, timelines, and budget
  • Successfully led local study teams at the global SMT
  • Coached and provided indirect line management support in partnership with the relevant managers to GNE in-house study team members
  • Coordinated and organized off-site training, Investigator Meetings, and DMC Meetings
  • Provided oversight, leadership, and support to CRO staff and Clinical Trial Assistants to ensure overall delivery at the country and site level
  • Supervised/collaborated in the preparation of local quality/compliance reviews, internal audits, and regulatory inspections to ensure adequate and timely CAPA follow-up
  • Articulated audit findings, risks and detailed recommendations to upper management.

Sr. Clinical Research Associate

Titan Pharmaceuticals, Inc.
South San Francisco, CA
11.2001 - 08.2005
  • Conducted project start-up activities such as investigator identification by researching and compiling names of potential Investigators for a Phase II pivotal study
  • Performed monitoring visits in compliance with the study-specific Monitoring Plan, Standard Operating Procedures, Good Clinical Practices (GCP) and applicable government regulations and guidelines; ensure site compliance to protocol, review investigator site file, perform source document verification (SDV), query resolution, and documents adverse events
  • (International/US base)
  • Identified, resolved, mitigated and escalated risks and/or issues to the study team while working independently and with team support
  • Designed and developed key clinical study documents (e.g
  • Informed consent forms, study specific plans, study master file plan) and participated in the preparation of data management plan (DMP)
  • Reviewed and verified data in CRFs (Case Report Forms), CTPs, IPORFs, and ICFs with source documents
  • Coordinated an Expert Panel conference, Study Kick-Off meeting, off-site training and Investigator Meeting.

Clinical Project Coordinator/Trial Assistant

AGY Therapeutics, Inc.
South San Francisco, CA
12.2000 - 11.2001
  • Updated the Patient Tracking Database which includes details of patient recruitment into clinical trials, progress through the trial, payments due to investigators, amounts paid to sites, adverse events and other relevant patient related information
  • Managed research and development projects, including timelines and deliverables
  • Coordinated with outside counsel to execute and file assignments, declarations, affidavits, and similar patent documents
  • Oversaw the execution and renewal of material transfer agreements, non-disclosure, and research agreements
  • Transferred data from the CRFs into the database
  • Conducted SBIR/SBTTR research/filing.

Education

Bachelor of Arts - Business Law

University of AZ (formerly Ashford University)
Chandler, AZ
06-2011

Bachelor of Arts - Health Administration

University of AZ (formerly Ashford University)
Chandler, AZ
06-2011

Bachelor of Arts - Business Law

Skyline College
San Bruno, CA

Master of Science - Criminal & Social Justice

University of AZ (formerly Ashford University)
Chandler, AZ

Master of Science - Health Care Administration

University of AZ (formerly Ashford University)
Chandler, AZ

Skills

  • Operations management with adherence to FDA/EU/AUS/NZL Regulations10 years managing multiple global phase I to IV clinical drug studies in the following therapeutic areas:
  • Oncology (NSCLC/SCLC HCC, RCC, GI, GU, CRC, bone, OC, BRCA)
  • Immunology,
  • Pulmonary,
  • CNS (Ischemia Damage, Parkinson Disease, Alzheimer)
  • Drug Addiction (Opiod)
  • Rare Genetic Disease (Morquio, Pompe, CDD, CDKL5, BRCA,)
  • Cardiovascular
  • Ophthalmology (Wet/Dry AMD)
  • GLP1
  • Proficiency in managing clinical trials involving drugs, medical devices, and combination products
  • Team leader and mentor for clinical trial managers operating global studies in NA, EU and Asia Pacific
  • Operational Point Person for the Following CROs: PRA Health Sciences, ICON, Syneos, Quintiles, PPD, Signant Health Sciences, etc
  • Implementer of SOPs per ICH Guidelines and Provider of GCP Expertise for Multiple Companies
  • Manager of External Investigator Meetings (Start-Up, Manage, Participate, and Present)

CLINICAL RESEARCH STUDIES

Allurion Technologies 

MAR 2023 - JAN 2024

  • A Prospective, Open-Label, Multi-Center, Randomized, Pivotal Safety and Efficacy Study of the Allurion Gastric Balloon System + Moderate Intensity Lifestyle Modification Therapy Program vs. Moderate Intensity Lifestyle Modification Therapy Program for the Treatment of Adults with Obesity

ZOGENIX, INC (now UCB)

JUL 2020 – SEP 2022

  • Fenfluramine for the treatment of refractory Epilepsy in Adult Dravet patients
  • Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)
  • A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
  • A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder
  • Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes

ROCHE/GENENTECH

SEP 2018 – MAY 2020  

  • A Phase II, Multi-Center, Randomized, Active Treatment-Controlled Study of the Efficacy and Safety of Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration (ARCHWAY)
  • A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System with Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (PORTAL)
  • Study of the Efficacy and Safety of the Ranibizumab Port Delivery System (RPDS) for Sustained Delivery of Ranibizumab in Participants with Subfoveal Neovascular Age-Related Macular Degeneration (AMD) (LADDER)
  • A Phase III, Multi-Center, Randomized Visual Assessor-Masked, Active Comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System with Ranibizymab in Patients with Diabetic Macular Edema (PAGODA)
  • A Phase III, Multi-Center, Randomized Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System with Ranibizumab in Patients with Diabetic Retinopathy (PAVILION)

Genentech

AUG 2005 - JUL 2007

  • A Study to Evaluate Bevacizumab Alone or in Combination with Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
  • A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants with Chronic Idiopathic Urticaria (OCEAN)
  • A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Safety and Efficacy of HAE1 (PRO98498) in Subjects with Moderate to Severe Allergic Asthma

EXELIXIS

JAN 2017 - JUL 2018

  • A Phase 3, Randomized Double-Blind, Placebo-Controlled Study of Cabozantinib (XL184) in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed after Prior VEGFR-Targeted Therapy (COSMIC-311)
  • Study of Cabozantinib in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors (COSMIC-021).
  • A Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Cabozantinib (XL184) at 60 mg/Day Compared to a 140 mg/Day in Progressive, Metastatic Medullary Thyroid Cancer Patients (EXAMINER).
  • Study of Cabozantinib (XL184) vs Placebo in Subjects with Hepatocellular Carcinoma Who Have Received Prior Sorafenib (CELESTIAL)

BIOMARIN PHARMACEUTICAL, INC.

MAR 2014  - JAN 2017

  • Safety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) Patients.
  • Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children with PKU.
  • A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease.
  • Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects with PKU (PAL-003)
  • Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects with Phenylketonuria (PKU).
  • Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients with Late-Onset Pompe Disease (POM-001) Extension Study for Patients Who Have Participated in a BMN 701 Stud (POM002)
  • Safety/Tolerability/Pharmacokinetic (PK)/Pharmacodynamics (PD) Study of BMN701 in Patients with Late-Onset Pompe Disease (POM-003)

TITAN PHARMACEUTICALS, INC.

NOV 2001 – AUG 2005

  • Stereotactic Intrastriatal Implantation of Spheramine in Advanced Parkinson'sDisease Patients: A Pilot Study of Tolerability and Efficacy
  • Study of the Safety, Tolerability and Efficacy of Spheramine Implanted Bilaterally Into the Postcommissural Putamen of Patients With Advanced Parkinson's Disease (STEPS)
  • A Randomized, Multi-Center, Double-Blind Dose Controlled Study of Probuphine in Patients with Opioid Dependence (Drug Addiction).
  • Ceavac: Murine Monoclonal Antibody (3HI) that mimics Carcinoembryonic Antigen (CAE).
  • TriAb: Murine Monoclonal Antibody Anti-Idiotype (11D10) that mimics the Human Milk Fat Globule (HMFG) Antigen.
  • A Randomized, Serum-Level Targeted Study Investigating the Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Patients with Various Refractory Malignancies (Bone Cancer).
  • Stereotactic Intrastriatal Implantation of Spheramine implanted bilaterally into the post-commissural putamen of patients with Advance Parkinson's disease.
  • A Double-Blind, Randomized, Parallel-Group, Two-Arm, placebo-controlled, Multicenter Evaluation of Ceavac (3H1).
  • Anti-Idiotypic Antibody in the Management of Patients with Stage IV Colon or Rectal Carcinomas receiving Flu Orouracil (5-Fu) plus Leucovorin (Ceavac - 208A).
  • Double-Blind, Randomized, Placebo-controlled, Multi-center Evaluation of Ceavac (3H1).
  • Anti-Idiotypic Monoclonal Antibody in the Management of Patients with Stage IV Color on Rectal Carcinomas Who have refused or are Unsuitable for Chemotherapy (Ceavac - 208B)

Timeline

Clinical Site Manager/Monitor

Allurion Technologies
03.2023 - Current

Sr. Director, Clinical Operations (Early Dev).

Circle Pharma
03.2023 - 01.2024

Associate Director

Zogenix
07.2020 - Current

Global Studies Manager (contract)

Roche/Genentech
09.2018 - 05.2020

Associate Director, Clinical Operations

Exelixis, Inc.
01.2017 - 07.2018

Sr. Clinical Operations Manager/Global Study Lead

BioMarin Pharmaceutical, Inc.
03.2014 - 01.2017

Sr. Clinical Research Associate

BioMarin Pharmaceutical, Inc.
02.2010 - 03.2014

Sr. Clinical Research Associate (contract)

Abbott Vascular
06.2008 - 09.2009

Clinical Program Manager (contract)

CoMentis, Inc.
06.2007 - 06.2008

Clinical Trial Manager

Genentech, Inc.
08.2005 - 07.2007

Sr. Clinical Research Associate

Titan Pharmaceuticals, Inc.
11.2001 - 08.2005

Clinical Project Coordinator/Trial Assistant

AGY Therapeutics, Inc.
12.2000 - 11.2001

Bachelor of Arts - Business Law

University of AZ (formerly Ashford University)

Bachelor of Arts - Health Administration

University of AZ (formerly Ashford University)

Bachelor of Arts - Business Law

Skyline College

Master of Science - Criminal & Social Justice

University of AZ (formerly Ashford University)

Master of Science - Health Care Administration

University of AZ (formerly Ashford University)
CAROL SICHELMEIER